Provided by Tiger Trade Technology Pte. Ltd.

JACOBIO-B

7.410
+0.5007.24%
Volume:2.49M
Turnover:18.29M
Market Cap:5.82B
PE:-34.54
High:7.460
Open:7.060
Low:6.980
Close:6.910
52wk High:11.800
52wk Low:2.350
Shares:786.00M
HK Float Shares:786.00M
Volume Ratio:1.14
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.215
ROE:-17.24%
ROA:-7.80%
PB:6.64
PE(LYR):-34.54
PS:95.59

Loading ...

AstraZeneca Joins the Fray: The Battle Over Pan-KRAS Inhibitor Technology Begins to Shift

Stock News
·
Dec 22, 2025

China Shenhua (01088) Launches 100 Billion Yuan Asset Restructuring; COMEX Silver Hits Record High

Stock News
·
Dec 22, 2025

Jacobio Pharma Enters Global Exclusive License Agreement With AstraZeneca for Pan-Kras Inhibitor Jab-23E73

THOMSON REUTERS
·
Dec 21, 2025

JACOBIO-B (01167) Subsidiary Enters Licensing Agreement with AstraZeneca to Develop and Commercialize Pan-KRAS Inhibitor JAB-23E73

Stock News
·
Dec 21, 2025

Jacobio Pharmaceuticals Partners with AstraZeneca on Pan-KRAS Inhibitor JAB-23E73

Reuters
·
Dec 21, 2025

HK Movers | Biomedical Stocks Jump With Xuanzhu Biopharmaceutical up 22%

Tiger Newspress
·
Dec 12, 2025

HK Stock Movement | JACOBIO-B (01167) Surges Over 11% Again After Receiving RMB125M Initial Payment from Oceanpine Capital

Stock News
·
Dec 10, 2025

Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Simply Wall St.
·
Dec 08, 2025

HK Stock Movement | JACOBIO-B (01167) Surges Over 6% Intraday as Subsidiary Receives RMB125M Upfront Payment and Combination Therapy Published in The Lancet

Stock News
·
Dec 04, 2025

Jacobio (01167) Announces November 2025 Share Repurchase Data

Bulletin Express
·
Dec 03, 2025

Jacobio Pharmaceuticals Unit Receives Upfront Payment From Oceanpine Capital; Shares Lose 3%

MT Newswires Live
·
Dec 03, 2025

JACOBIO-B (01167) Receives First Payment Under Capital Increase and Equity Transfer Agreements

Stock News
·
Dec 02, 2025

Jacobio Unveils Positive Clinical Data for KRAS G12C and SHP2 Inhibitor Combination in The Lancet Respiratory Medicine

Reuters
·
Dec 01, 2025

Jacobio (1167) Announces Positive Phase I/IIa Results for KRAS G12C + SHP2 Inhibitor Combination

Bulletin Express
·
Dec 01, 2025

JACOBIO-B (01167): KRAS G12C and SHP2 Combination Therapy Data Published in The Lancet Respiratory Medicine

Stock News
·
Dec 01, 2025

Rock star Growth Puts Jacobio Pharmaceuticals Group (HKG:1167) In A Position To Use Debt

Simply Wall St.
·
Nov 26, 2025

HK Stock Movement | JACOBIO-B (01167) Rises Over 5% as Pan-KRAS Inhibitor JAB-23E73 Expected to Release Phase 1 Data in H1 2026

Stock News
·
Nov 20, 2025

Jacobio Pharmaceuticals Says Andrea Wang-Gillam Appointed As Co-CEO

Reuters
·
Nov 20, 2025

Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast

Stock News
·
Nov 18, 2025

JACOBIO-B Surges Over 5% in Morning Session as Company Establishes Co-CEO System

Deep News
·
Nov 14, 2025